These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37236125)

  • 1. EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma.
    Umemori K; Ono K; Eguchi T; Kawai H; Nakamura T; Ogawa T; Yoshida K; Kanemoto H; Sato K; Obata K; Ryumon S; Yutori H; Katase N; Okui T; Nagatsuka H; Ibaragi S
    Oral Oncol; 2023 Jul; 142():106433. PubMed ID: 37236125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells.
    Liang KH; Tso HC; Hung SH; Kuan II; Lai JK; Ke FY; Chuang YT; Liu IJ; Wang YP; Chen RH; Wu HC
    Cancer Lett; 2018 Oct; 433():165-175. PubMed ID: 29981429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers.
    Pan M; Schinke H; Luxenburger E; Kranz G; Shakhtour J; Libl D; Huang Y; Gaber A; Pavšič M; Lenarčič B; Kitz J; Jakob M; Schwenk-Zieger S; Canis M; Hess J; Unger K; Baumeister P; Gires O
    PLoS Biol; 2018 Sep; 16(9):e2006624. PubMed ID: 30261040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis.
    Warneke VS; Behrens HM; Haag J; Krüger S; Simon E; Mathiak M; Ebert MP; Röcken C
    Br J Cancer; 2013 Oct; 109(8):2217-27. PubMed ID: 24008668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer.
    Fong D; Moser P; Kasal A; Seeber A; Gastl G; Martowicz A; Wurm M; Mian C; Obrist P; Mazzoleni G; Spizzo G
    Histopathology; 2014 Apr; 64(5):683-92. PubMed ID: 24117877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpCAM and EGFR crosstalk in the development of resistance towards Cetuximab treatment in head and neck cancer.
    He M; Gouda M; Gires O
    Oral Oncol; 2023 Aug; 143():106465. PubMed ID: 37348447
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression.
    Panda SS; Lee CC; Geevimaan K; Chen KC; Yang SH; Shen CN; HuangFu WC; Wu HC
    J Biomed Sci; 2024 Jul; 31(1):72. PubMed ID: 39010070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc.
    Jedlinski A; Garvin S; Johansson AC; Edqvist PH; Ponten F; Roberg K
    J Oral Pathol Med; 2017 Oct; 46(9):717-724. PubMed ID: 28036101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is biomarker research advancing in the era of personalized medicine for head and neck cancer?
    Yokota T
    Int J Clin Oncol; 2014 Apr; 19(2):211-9. PubMed ID: 24442754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines.
    De Pauw I; Wouters A; Van den Bossche J; Deschoolmeester V; Baysal H; Pauwels P; Peeters M; Vermorken JB; Lardon F
    Cancer Biother Radiopharm; 2017 Sep; 32(7):229-238. PubMed ID: 28910149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status.
    Baysal H; De Pauw I; Zaryouh H; De Waele J; Peeters M; Pauwels P; Vermorken JB; Smits E; Lardon F; Jacobs J; Wouters A
    Br J Cancer; 2020 Sep; 123(5):752-761. PubMed ID: 32541873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer.
    Mu L; Zhang J; Wu Z; Huang J; Cui Y
    J Healthc Eng; 2022; 2022():6108241. PubMed ID: 35126932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma.
    Li C; Iida M; Dunn EF; Wheeler DL
    Radiother Oncol; 2010 Nov; 97(2):330-7. PubMed ID: 20667610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer.
    Nair S; Trummell HQ; Rajbhandari R; Thudi NK; Nozell SE; Warram JM; Willey CD; Yang ES; Placzek WJ; Bonner JA; Bredel M
    PLoS One; 2020; 15(2):e0229077. PubMed ID: 32069320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cetuximab in the treatment of squamous cell cancer of the head and neck.
    Burtness B
    Expert Opin Biol Ther; 2005 Aug; 5(8):1085-93. PubMed ID: 16050785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine promotes lymph node metastasis and cetuximab resistance in head and neck squamous cell carcinoma.
    Shimizu R; Ibaragi S; Eguchi T; Kuwajima D; Kodama S; Nishioka T; Okui T; Obata K; Takabatake K; Kawai H; Ono K; Okamoto K; Nagatsuka H; Sasaki A
    Int J Oncol; 2019 Jan; 54(1):283-294. PubMed ID: 30431077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines.
    Oshima G; Wennerberg J; Yamatodani T; Kjellén E; Mineta H; Johnsson A; Ekblad L
    J Cancer Res Clin Oncol; 2012 Mar; 138(3):491-9. PubMed ID: 22193422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extracellular domain of epithelial cell adhesion molecule (EpCAM) enhances multipotency of mesenchymal stem cells through EGFR-LIN28-LET7 signaling.
    Kuan II; Lee CC; Chen CH; Lu J; Kuo YS; Wu HC
    J Biol Chem; 2019 May; 294(19):7769-7786. PubMed ID: 30926604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EpEX/EpCAM and Oct4 or Klf4 alone are sufficient to generate induced pluripotent stem cells through STAT3 and HIF2α.
    Kuan II; Liang KH; Wang YP; Kuo TW; Meir YJ; Wu SC; Yang SC; Lu J; Wu HC
    Sci Rep; 2017 Feb; 7():41852. PubMed ID: 28157205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial Cell Adhesion Molecule in Primary Sjögren's Syndrome Patients: Characterization and Evaluation of a Potential Biomarker.
    Zhang K; Zhou Y; Cheng X; Fu X; Du W; Feng Y; Jia J; Yang X; Xiao G; Zheng Z; Zhu P; Wu Z
    J Immunol Res; 2019; 2019():3269475. PubMed ID: 31886299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.